Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status

Title
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status
Authors
Keywords
Src, NSCLC, EGFR inhibitors, MEK inhibitors, drug resistance
Journal
Oncotarget
Volume 6, Issue 28, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-29
DOI
10.18632/oncotarget.4636

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started